Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,410.00
Bid: 2,400.00
Ask: 2,420.00
Change: -60.00 (-2.43%)
Spread: 20.00 (0.833%)
Open: 2,465.00
High: 2,510.00
Low: 2,410.00
Prev. Close: 2,470.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

16 Jan 2014 07:00

RNS Number : 7769X
Craneware plc
16 January 2014
 



 Craneware plc

("Craneware", "the Group" or the "Company")

 

Trading Update and Notice of Results

 

16 January 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, provides an update on trading for the six months ended 31 December 2013.

 

The Group has continued to see positive momentum in sales through the period, driven by a strengthened sales operation and supportive market environment. The majority of revenue and margin resulting from sales in the period will be recognised over future periods as per the Company's normal revenue recognition policy, adding to the Group's long term visibility of revenue under contract.

 

The Company expects to report recognised revenue and EBITDA increases of 5% for the six months ended 31 December 2013 compared with the same period last fiscal year. This is in line with management's expectations for the H1 to H2 split, which, together with the continuing positive sales momentum, provides the board with confidence in meeting market expectations for the full year.

 

Keith Neilson, CEO of Craneware plc commented, "The continued incremental increases in the size of hospital groups, overall deal size and increasing number of longer term contracts signed during the period provided a strong sales performance and resulted in recognised revenue and EBITDA growth. Importantly, the increased sales activity will flow through into revenue and EBITDA contribution in the second half of the year and beyond, providing further visibility over future contracted revenues and supporting continued growth."

 

The Company will announce its Interim Results on 11 March 2014.

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Evans-Jones

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAPFSFASLEFF
Date   Source Headline
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSFY23 Trading Update and Notice of Results
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20234:44 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20237:00 amRNSTransaction in Own Shares
5th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.